Other hTERT activation pathways that are frequently deregulated in various cancer settings include those influenced by CDK2 and CDK4 [226] and AKT [227], whereas deregulated repression pathways include those influenced by TGFβ [228], TNFα [229], and other cell cycle inhibitors [230]. The gene discussed is CDK4; the disease is cancer.